This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1998-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bethesda, MD (US) (1998 - 1999)
- Naples, IT (2005)
Company Filing History:


Years Active: 1998-2005
Title: Luigi Racioppi: Innovator in Immunomodulatory Research
Introduction
Luigi Racioppi is a notable inventor based in Bethesda, MD (US), recognized for his contributions to the field of immunology. He holds a total of 4 patents, focusing on T cell receptor ligands and their applications in modulating immune responses. His work has significant implications for therapeutic strategies in immunology.
Latest Patents
Among his latest patents, Racioppi has developed T cell receptor ligands with immunomodulatory properties. These inventions include methods for identifying such ligands and utilizing them to modulate T cell effector responses. His innovative approaches aim to enhance the understanding and treatment of immune-related conditions.
Career Highlights
Racioppi has worked with the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His career reflects a commitment to advancing medical research and improving health outcomes through innovative solutions.
Collaborations
Throughout his career, Racioppi has collaborated with esteemed colleagues, including Ronald N Germain and Franca Ronchese-Le Gros. These partnerships have contributed to the depth and impact of his research in the field of immunology.
Conclusion
Luigi Racioppi's work in developing T cell receptor ligands showcases his dedication to advancing immunological research. His patents and collaborations highlight his significant contributions to the field, paving the way for future innovations in immune modulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile